## Abstract In this paper, we investigated whether protein kinase C‐ζ (PKCζ), a member of the atypical PKC family, induces phenotypic alterations associated with malignant transformation and tumor progression in mammary cells. The stable overexpression of PKCζ in immortalized mammary epithelial cel
Protein kinase C δ enhances proliferation and survival of murine mammary cells
✍ Scribed by Valeria C. Grossoni; Karina B. Falbo; Marcelo G. Kazanietz; Elisa D. Bal de Kier Joffé; Alejandro J. Urtreger
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 307 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20287
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Protein kinase C (PKC) δ, a member of the novel family of PKC serine‐threonine kinases, has been implicated in negative regulation of proliferation and apoptosis in a large number of cell types, including breast cancer cell lines, and postulated as a tumor suppressor gene. In this study we show that in murine NMuMG mammary cells PKCδ promotes a mitogenic response. Overexpression of PKCδ in NMuMG cells leads to a significant increase in [^3^H]‐tymidine incorporation and cell proliferation, as well as enhanced extracellular signal‐regulated kinase (ERK)‐mitogen‐activated protein kinase (MAPK) activation. Activation of PKCδ with a phorbol ester leads to elevated cyclin D1 expression and an hyperphosphorylated Rb state. Surprisingly, ectopic expression of PKCδ conferred anchorage‐independent growth capacity to NMuMG cells. PKCδ overexpressors showed enhanced resistance to apoptotic stimuli, such as serum deprivation or doxorubicin treatment, an effect that correlates with hyperactivation of the Akt survival pathway. Our results provide evidence for a role of PKCδ as a positive modulator of proliferative and survival signals in immortalized mammary cells. The fact that PKCδ exerts differential responses depending on the cell context not only highlights the necessity to carefully understand the signaling events controlled by this PKC in each cell type but also suggests that we should be cautious in considering this kinase a target for cancer therapy. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Previous studies from our laboratory have demonstrated the presence of several isoforms of protein kinase C (PKC), Caz+-independent and Ca2+-dependent, in both whole islets and tumor-derived beta cells. In the basal state, a major proportion of the isoform was found in the crude membrane fraction wi
In order to gain insight into the biological function of a PKC iso-enzyme, the protein kinase C, we analyzed the expression pattern of this protein in mouse epidermis and keratinocytes in culture. Daily analysis of neonatal mouse epidermis immediately after birth showed a time-dependent reduction in
## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in
We have previously identified expression of multiple protein kinase C (PKC) isoforms in insulinomaderived beta-cells and whole islets. Both PKC 6 and PKC a appear to be the more abundantly expressed isoforms. in this report we studied the effects of arachidonic acid (AA) on the subcellular distribut